Log in

BlueLinx Stock Forecast, Price & News

-0.18 (-0.98 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $18.14
50-Day Range
MA: $18.67
52-Week Range
Now: $18.14
Volume144,847 shs
Average Volume213,379 shs
Market Capitalization$171.62 million
P/E RatioN/A
Dividend YieldN/A
BlueLinx Holdings Inc., together with its subsidiaries, distributes building and industrial products in the United States. It distributes structural products, including plywood, oriented strand board, rebar and remesh, lumber, spruce, and other wood products primarily used for structural support, walls, and flooring in construction projects; and specialty products comprising engineered wood, moulding, siding, cedar, metal, and insulation products. The company also provides a range of value-added services and solutions to its customers. It serves dealers, industrial manufacturers, manufactured housing producers, and home improvement retailers through a network of distribution centers. BlueLinx Holdings Inc. was founded in 1996 and is headquartered in Marietta, Georgia.
Read More
BlueLinx logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars

Industry, Sector and Symbol

Industry Lumber, plywood, & millwork
Sub-IndustryTrading Companies & Distributors



Sales & Book Value

Annual Sales$2.64 billion
Cash Flow$2.02 per share
Book Value($2.79) per share


Net Income$-17,660,000.00


Market Cap$171.62 million
Next Earnings Date11/3/2020 (Estimated)
-0.18 (-0.98 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BXC News and Ratings via Email

Sign-up to receive the latest news and ratings for BXC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

BlueLinx (NYSE:BXC) Frequently Asked Questions

How has BlueLinx's stock been impacted by Coronavirus (COVID-19)?

BlueLinx's stock was trading at $5.53 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BXC stock has increased by 228.0% and is now trading at $18.14.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of BlueLinx?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BlueLinx in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for BlueLinx

When is BlueLinx's next earnings date?

BlueLinx is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for BlueLinx

How were BlueLinx's earnings last quarter?

BlueLinx Holdings Inc. (NYSE:BXC) posted its earnings results on Monday, August, 3rd. The construction company reported $0.71 EPS for the quarter, beating the consensus estimate of ($0.41) by $1.12. The construction company had revenue of $698.78 million for the quarter, compared to the consensus estimate of $619.11 million.
View BlueLinx's earnings history

What price target have analysts set for BXC?

1 analysts have issued 12 month target prices for BlueLinx's shares. Their forecasts range from $19.00 to $19.00. On average, they anticipate BlueLinx's stock price to reach $19.00 in the next year. This suggests a possible upside of 4.7% from the stock's current price.
View analysts' price targets for BlueLinx

Are investors shorting BlueLinx?

BlueLinx saw a decrease in short interest in August. As of August 31st, there was short interest totaling 269,000 shares, a decrease of 19.0% from the August 15th total of 332,100 shares. Based on an average trading volume of 230,500 shares, the short-interest ratio is presently 1.2 days. Approximately 3.0% of the shares of the stock are sold short.
View BlueLinx's Short Interest

Who are some of BlueLinx's key competitors?

What other stocks do shareholders of BlueLinx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlueLinx investors own include Novavax (NVAX), Micron Technology (MU), Co-Diagnostics (CODX), Livongo Health (LVGO), Intel (INTC), Civeo (CVEO), Maxar Technologies (MAXR), Sorrento Therapeutics (SRNE), Hologic (HOLX) and Inovio Pharmaceuticals (INO).

Who are BlueLinx's key executives?

BlueLinx's management team includes the following people:
  • Mr. Mitchell B. Lewis, Pres, CEO & Director (Age 57)
  • Ms. Susan C. O'Farrell, Sr. VP, CFO, Treasurer & Principal Accounting Officer (Age 55)
  • Mr. Shyam K. Reddy, Sr. VP & Chief Transformation Officer (Age 44)
  • Mr. Alexander S. Averitt, Chief Operating Officer (Age 42)
  • Mr. Justin B. Heineman, VP, Gen. Counsel & Corp. Sec. (Age 47)

What is BlueLinx's stock symbol?

BlueLinx trades on the New York Stock Exchange (NYSE) under the ticker symbol "BXC."

Who are BlueLinx's major shareholders?

BlueLinx's stock is owned by many different retail and institutional investors. Top institutional investors include Acuitas Investments LLC (2.11%), Bridgeway Capital Management Inc. (0.52%), Perritt Capital Management Inc. (0.47%), Jane Street Group LLC (0.38%), PDT Partners LLC (0.37%) and State of Wisconsin Investment Board (0.15%). Company insiders that own BlueLinx stock include Alexander S Averitt, Brian J Sasadu, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Nokomis Capital, LLC, Shyam K Reddy and Susan C O'farrell.
View institutional ownership trends for BlueLinx

Which major investors are selling BlueLinx stock?

BXC stock was sold by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc., and Bank of America Corp DE.
View insider buying and selling activity for BlueLinx

Which major investors are buying BlueLinx stock?

BXC stock was bought by a variety of institutional investors in the last quarter, including Acuitas Investments LLC, Jane Street Group LLC, PDT Partners LLC, Bridgeway Capital Management Inc., State of Wisconsin Investment Board, Goldman Sachs Group Inc., and Captrust Financial Advisors. Company insiders that have bought BlueLinx stock in the last two years include Alexander S Averitt, Brian J Sasadu, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Nokomis Capital, LLC, Shyam K Reddy, and Susan C O'farrell.
View insider buying and selling activity for BlueLinx

How do I buy shares of BlueLinx?

Shares of BXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BlueLinx's stock price today?

One share of BXC stock can currently be purchased for approximately $18.14.

How big of a company is BlueLinx?

BlueLinx has a market capitalization of $171.62 million and generates $2.64 billion in revenue each year. The construction company earns $-17,660,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis. BlueLinx employs 2,200 workers across the globe.

What is BlueLinx's official website?

The official website for BlueLinx is www.bluelinxco.com.

How can I contact BlueLinx?

BlueLinx's mailing address is 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067. The construction company can be reached via phone at 770-953-7000 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.